The myofibroblast in wound healing and fibrocontractive diseases.
Journal article

The myofibroblast in wound healing and fibrocontractive diseases.

  • Gabbiani G Department of Pathology, CMU University of Geneva, 1 rue Michel-Servet, 1211 Geneva 4, Switzerland. giulio.gabbiani@medicine.unige.ch
  • 2003-07-08
Published in:
  • The Journal of pathology. - 2003
English The demonstration that fibroblastic cells acquire contractile features during the healing of an open wound, thus modulating into myofibroblasts, has open a new perspective in the understanding of mechanisms leading to wound closure and fibrocontractive diseases. Myofibroblasts synthesize extracellular matrix components such as collagen types I and III and during normal wound healing disappear by apoptosis when epithelialization occurs. The transition from fibroblasts to myofibroblasts is influenced by mechanical stress, TGF-beta and cellular fibronectin (ED-A splice variant). These factors also play important roles in the development of fibrocontractive changes, such as those observed in liver cirrhosis, renal fibrosis, and stroma reaction to epithelial tumours.
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://folia.unifr.ch/global/documents/5334
Statistics

Document views: 23 File downloads: